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Abstract: Heteromeric amino acid transporters (HATs) are protein complexes that catalyze the
transport of amino acids across plasma membranes. HATs are composed of two subunits, a heavy
and a light subunit, which belong to the solute carrier (SLC) families SLC3 and SLC7. The two
subunits are linked by a conserved disulfide bridge. Several human diseases are associated with
loss of function or overexpression of specific HATs making them drug targets. The human HAT
4F2hc-LAT2 (SLC3A2-SLC7A8) is specific for the transport of large neutral L-amino acids and specific
amino acid-related compounds. Human 4F2hc-LAT2 can be functionally overexpressed in the
methylotrophic yeast Pichia pastoris and pure recombinant protein purified. Here we present the
first cryo-electron microscopy (cryo-EM) 3D-map of a HAT, i.e., of the human 4F2hc-LAT2 complex.
The structure could be determined at ~13 Å resolution using direct electron detector and Volta phase
plate technologies. The 3D-map displays two prominent densities of different sizes. The available
X-ray structure of the 4F2hc ectodomain fitted nicely into the smaller density revealing the relative
position of 4F2hc with respect to LAT2 and the membrane plane.
Keywords: 4F2hc; cryo-EM; direct electron detector; heteromeric amino acid transporter; LAT2;
L-type amino acid transporter; SLC3; SLC7; Volta phase plate
1. Introduction
Amino acids are fundamental nutrients and are involved in numerous cellular processes ranging
from energy production to signaling and protein synthesis. Transport of amino acids and amino acid
derivatives across the plasma membrane is achieved by amino acid transporters belonging to different
solute carrier (SLC) families (available online: http://slc.bioparadigms.org). From these families,
the SLC7 family of amino acid transporters is composed of 15 members that belong to the large amino
acids, polyamines, and organocations (APC) superfamily of transporters [1]. SLC7 family members are
subdivided in two groups, the cationic amino acid transporters (CATs; SLC7A1-4 and SLC7A14) and
the L-type amino acid transporters (LATs; SLC7A5-13 and SLC7A15). LATs are glycoprotein-associated
amino acid transporters, i.e., the catalytic (light) subunits of these heteromeric amino acid transporters
(HATs) are associated with the heavy subunits 4F2hc (SLC3A2) or rBAT (SLC3A1) from the SLC3
family [1]. A conserved disulfide bridge covalently links the two HAT subunits [1–3]. The amino
acid transporter LAT2 (SLC7A8) preferably transports large neutral L-amino acids and functions as
obligatory exchanger [4]. It is associated with the heavy chain subunit 4F2hc (CD98), which is a type II
membrane N-glycoprotein. 4F2hc comprises a small N-terminal cytoplasmic domain, followed by a
single transmembrane domain (TMD) and a large C-terminal ectodomain (ED) [1,5], whose structure
was solved [6]. The heavy subunit is responsible for stabilization of the 4F2hc-LAT2 heterodimeric
complex and its correct trafficking to the plasma membrane [7,8]. The light subunit LAT2 is highly
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hydrophobic, not glycosylated, and responsible for substrate transport. It is predicted to contain
twelve TMDs with internal N- and C-termini [1,4]. Human nuisances and severe diseases such as
age-related hearing loss, renal aminoaciduria, and cancer are associated with a loss of transporter
function or overexpression of LAT2 [1,9–11].
A few years ago, the heterologous expression of human light and heavy subunits using the
methylotrophic yeast Pichia pastoris as expression system was reported [12]. The most successfully
overexpressing subunits turned out to be 4F2hc and LAT2. Co-transformation and -expression of
these two subunits yielded functional complexes of 4F2hc-LAT2 connected by the conserved disulfide
bridge [12]. For structural studies, the human 4F2hc-LAT2 heterodimeric complex was overexpressed
containing N-terminal affinity tags, i.e., His-tagged 4F2hc and Strep-tagged LAT2, and purified
from detergent-solubilized membranes [7,13]. The transport activity of recombinant 4F2hc-LAT2
was confirmed by L-leucine uptake experiments using either Pichia cells or proteoliposomes [7,12].
3D-maps at about 20 Å resolution of the 4F2hc-LAT2 complex were obtained using single particle
analysis and negative-stain electron microscopy [7,13]. These maps provided first insights into the
supramolecular organization of human 4F2hc-LAT2 at low resolution.
In recent years, the field of electron microscopy (EM) has undergone a revolution in terms of
resolution. The main factors for this are the introduction of improved hardware, e.g., direct electron
detectors, and software for image processing and automated data acquisition [14–16]. Furthermore,
structure solution of difficult protein samples as small, heterogeneous, and flexible proteins is facilitated
by the introduction of the Volta phase plate (VPP) device into electron microscopes [17]. This technology
increases the contrast of electron micrographs and thus supports the structure solution of relatively
small proteins [18]. Here we present the first cryo-EM 3D-map of a HAT, i.e., of the human 4F2hc-LAT2
complex. This structure at ~13 Å resolution was successfully obtained using the direct electron detector
and VPP technologies. The available X-ray structure of 4F2hc-ED was fitted into the obtained density
of human 4F2hc-LAT2 and revealed the relative positions of the heavy subunit with respect to the light
subunit and the membrane plane.
2. Results and Discussion
The recombinant 4F2hc-LAT2 complex was overexpressed using the methylotropic yeast P. pastoris
and purified using Ni-nitrilotriacetic acid (NTA) affinity chromatography from lauryl maltose
neopentyl glycol (LMNG)/cholesteryl hemisuccinate (CHS) solubilized membranes. The purified
protein complex was pure and correctly assembled as reflected by a prominent band in the Coomassie
Brilliant Blue stained blue native (BN)-polyacrylamid gel (Figure 1A). Correct assembly of the complex
was further confirmed using Western blot analysis, which revealed the presence of both proteins, 4F2hc
and LAT2, in this major band (Figure 1B,C). According to BN-polyacrylamide gel electrophoresis
(BN-PAGE), the molecular weight (MW) of the detergent-solubilized, purified complex was estimated
at about 230 kDa, whereas the calculated MW of the complex based on the primary amino acid
sequences of 4F2hc and LAT2 is about 120 kDa. Therefore, the LMNG/CHS micelle of the protein
complex and co-purified lipids accounts for almost halve of the total MW. On the basis of the primary
amino acid sequences, an approximate two-fold increase in MW of membrane transport proteins
containing a comparable amount of TMDs as 4F2hc-LAT2, analyzed using BN-PAGE, were reported,
supporting our result [19,20]. Inspection of the gel revealed a faint secondary band migrating at
higher MW, i.e., at about 450 kDa. Western blot analysis clearly showed that both proteins, 4F2hc
and LAT2, are present in this band (Figure 1B,C). This hints at the formation of dimers of 4F2hc-LAT2
heterodimeric complexes, possibly due to unspecific aggregation as previously reported [7,13].
Detergent-solubilized 4F2hc and LAT2 originating from disrupted heteromeric complexes are expected
to be smaller in size than its complex and would therefore migrate to lower MWs than 230 kDa (for
SDS-PAGE analysis of 4F2hc-LAT2 under reducing and non-reducing conditions see [7,12,13]). Since
no protein bands below 230 kDa were detected using BN-PAGE and Western blot analysis (Figure 1),
the use of LMNG/CHS detergent mixture for purification turned out to be beneficial for 4F2hc-LAT2
heterodimer stability.
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Figure 1. Blue native-PAGE and Western blot analysis of purified human 4F2hc-LAT2 heterodimeric 
complex. Panel (A) displays a Coomassie Brilliant Blue stained 4-16% gradient blue-native gel of 
purified 4F2hc-LAT2. Western blot analyses using anti-His (B) and anti-Strep antibodies (C) indicate 
purity and correct assembly of the complex. The heterodimeric complex migrates to about 230 kDa. 
The faint band above the 440 kDa marker is in good agreement with a dimer of the heterodimeric 
complex, possibly due to unspecific aggregation. Note that neither monomeric 4F2hc nor monomeric 
LAT2 are present in the sample. Five micrograms of purified protein was loaded per lane. 
Cryo-EM images of purified 4F2hc-LAT2 particles were initially recorded with a 200 kV FEI 
Tecnai F20 electron microscope equipped with a Falcon III direct electron detector camera. Electron 
micrographs revealed low contrast of 4F2hc-LAT2 particles, even at high defocus values. This is 
common in cryo-EM for relatively small proteins, rendering the use of a Volta phase plate (VPP) for 
contrast improvement beneficial [17]. Cryo-EM images were therefore recorded with the same 
electron microscope configuration and an activated VPP (Table S1). Dose-fractioned images were 
motion-corrected and the dataset was then refined by deselecting bad images, e.g., visually obviously 
ice-contaminated images and images with contrast transfer function (CTF) parameters outside the 
boundaries [21]. Remaining micrographs revealed a homogenous distribution of 4F2hc-LAT2 
particles as exemplified by Figure 2A. These particles show different views, of which the length of 
the longest axes ranges from 100 to 120 Å (Figure 2A, black arrows). Some particles were substantially 
larger and elongated, and their longer axes ranged from 180 Å to 200 Å in length (Figure 2A, white 
arrows). These larger particles may be attributed to dimers of 4F2hc-LAT2 complexes, as seen using 
BN-PAGE (Figure 1). During the particle picking procedure, these larger particles were excluded and 
only 4F2hc-LAT2 heterodimeric particles were picked and used for subsequent rounds of reference-
free 2D-classification. Representative examples of 2D-class averages are shown in Figure 2B depicting 
projections of the human 4F2hc-LAT2 heteromeric complex viewed from different angles. 4F2hc-
LAT2 projections reflecting views from the membrane plane clearly demonstrate the presence of a 
smaller and a larger density (Figure 2B, 2D-class averages marked with a red asterisk) comparable to 
the previously reported 2D-class averages based on negatively stained 4F2hc-LAT2 particles [7,13]. 
An initial 3D-model was calculated applying the recently implemented stochastic-gradient-descent 
algorithm of the RELION software [22]. After 3D-classification and several rounds of 3D-refinement, 
the final cryo-EM 3D-map was calculated from 47,933 particles. The resolution was determined to 
14.3 and 12.9 Å using the Fourier shell correlation (FSC) cut-off-criterion of 0.5 and 0.143 (gold 
standard), respectively (Figure 3A; Table S1) [23,24]. The obtained cryo-EM 3D-map resolution of ~13 
Å using a 200 kV FEI Tecnai F20 electron microscope is moderate and should be significantly 
improved using a cutting-edge microscope such as a Titan Krios. Plotting the angular distribution of 
particles used for the final 3D-map calculation revealed a relatively even angular particle distribution 
(Figure 3B). 
Figure 1. Blue native-PAGE and Western blot analysis of purified human 4F2hc-LAT2 heterodimeric
complex. Panel (A) displays a Coomassie Brilliant Blue stained 4-16% gradient blue-native gel of
purified 4F2hc-LAT2. Western blot analyses using anti-His (B) and anti-Strep antibodies (C) indicate
purity and correct assembly of the complex. The heterodimeric complex migrates to about 230 kDa.
The faint band above the 440 kDa marker is in good agreement with a dimer of the heterodimeric
complex, possibly due to unspecific aggregation. Note that neither monomeric 4F2hc nor monomeric
LAT2 are present in the sample. Five micrograms of purified protein was loaded per lane.
Cryo-EM images of purified 4F2hc-LAT2 particles were initially recorded with a 200 kV FEI
Tecnai F20 electron microscope equipped with a Falcon III direct electron detector camera. Electron
micrographs revealed low contrast of 4F2hc-LAT2 particles, even at high defocus values. This is
common in cryo-EM for relatively small proteins, rendering the use of a Volta phase plate (VPP)
for contrast improvement beneficial [17]. Cryo-EM images were therefore recorded with the same
electron microscope configuration and an activated VPP (Table S1). Dose-fractioned images were
motion-corrected and the dataset was then refined by deselecting bad images, e.g., visually obviously
ice-contaminated images and images with contrast transfer function (CTF) parameters outside the
boundaries [21]. Remaining micrographs revealed a homogenous distribution of 4F2hc-LAT2 particles
as exemplified by Figure 2A. These particles show different views, of which the length of the longest
axes ranges from 100 to 120 Å (Figure 2A, black arrows). Some particles were substantially larger
and elongated, and their longer axes ranged from 180 Å to 200 Å in length (Figure 2A, white arrows).
These larger particles may be attributed to dimers of 4F2hc-LAT2 complexes, as seen using BN-PAGE
(Figure 1). During the particle picking procedure, these larger particles were excluded and only
4F2hc-LAT2 heterodimeric particles were picked and used for subsequent rounds of reference-free
2D-classification. Representative examples of 2D-class averages are shown in Figure 2B depicting
projections of the human 4F2hc-LAT2 heteromeric complex viewed from different angles. 4F2hc-LAT2
projections reflecting views from the membrane plane clearly demonstrate the presence of a smaller and
a larger density (Figure 2B, 2D-class averages marked with a red asterisk) comparable to the previously
reported 2D-class averages based on negatively stained 4F2hc-LAT2 particles [7,13]. An initial
3D-model was calculated applying the recently implemented stochastic-gradient-descent algorithm
of the RELION software [22]. After 3D-classification and several rounds of 3D-refinement, the final
cryo-EM 3D-map was calculated from 47,933 particles. The resolution was determined to 14.3 and
12.9 Å using the Fourier shell correlation (FSC) cut-off-criterion of 0.5 and 0.143 (gold standard),
respectively (Figure 3A; Table S1) [23,24]. The obtained cryo-EM 3D-map resolution of ~13 Å using a
200 kV FEI Tecnai F20 electron microscope is moderate and should be significantly improved using a
cutting-edge microscope such as a Titan Krios. Plotting the angular distribution of particles used for
the final 3D-map calculation revealed a relatively even angular particle distribution (Figure 3B).
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Figure 2. Cryo-electron microscopy (cryo-EM) of purified 4F2hc-LAT2 and gallery of 2D-class 
averages. (A) Displayed is a representative cryo-EM image collected using the Volta phase plate 
(VPP). Two sets of particles with different lengths are discerned. Smaller particles are in a size range 
of 100–120 Å (black arrows) and significantly more abundant than larger particles (size range of 180–
200 Å, white arrows). (B) A gallery of 15 representative 2D-class averages is displayed and ordered 
according to decreasing number of particles assigned to each class. 2D-class averages labeled with a 
red asterisk reflect projections as viewed from the membrane plane indicating two differently sized 
densities. Protein density is black and white in panels (A) and (B), respectively. The scale bar in (A) 
is 300 Å and the frame size in (B) 227 Å. 
 
Figure 3. Resolution estimation and angular particle distribution. (A) The Fourier shell correlation 
(FSC) plot for the calculated 4F2hc-LAT2 3D-map indicated resolutions of 14.3 Å and 12.9 Å at cut-
offs of 0.5 and 0.143 (gold standard), respectively. (B) Angular distribution plots of particles included 
in the final 3D reconstruction viewed from the top and the side. The number of particles with 
respective orientations are represented by length and colored cylinders, ranging from blue to red. In 
the center, the cryo-EM 3D-map of 4F2hc-LAT2 is represented as yellow colored surface. 
i 2. Cryo-electron microscopy (cryo-EM) of purified 4F2hc-LAT2 and gallery of 2D-class average .
(A) Displayed is a repr sentativ cryo-EM image collected using th Volta phase plate (VPP). Two sets
of particles with different lengths are discerned. Smaller particles re in size range of 100–120 Å
(black arrows) and significantly more abundant than larger particles (size range of 180–200 Å, white
arrows). (B) A gallery of 15 representative 2D-class averages is displayed an ordere according to
decreasing number of particles assigned to each class. 2D-class averages labeled with a red asterisk
reflect projections as viewed from the membrane plane indicating two differently sized densities.
Protein density is black and white in panels (A) and (B), respectively. The scale bar in (A) is 300 Å and
the frame size in (B) 227 Å.
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Figure 3. Resolution estimation and angular particle distribution. (A) The Fourier shell correlation
(FSC) plot for the calculated 4F2hc-LAT2 3D-map indicated resolutions of 14.3 Å and 12.9 Å at cut-offs
of 0.5 and 0.143 (gold standard), respectively. (B) Angular distribution plots of particles included in
the final 3D reconstruction viewed from the top and the side. The number of particles with respective
orientations are represented by length and colored cylinders, ranging from blue to red. In the center,
the cryo-EM 3D-map of 4F2hc-LAT2 is represented as yellow colored surface.
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Consistent with the previously obtained negative-stain EM 3D-maps of 4F2hc-LAT2 [7,13], the here
presented cryo-EM 3D-map consists of two differently sized densities (Figure 4). Whereas the smaller
density was identified as the 4F2hc-ED density (ED-density), the larger one was attributed to LAT2
plus the N-terminal cytoplasmic domain and the one TMD of 4F2hc, and co-purified lipids embedded
in a LMNG/CHS micelle (TMD-density). If viewed from the extracellular side, the ED-density is
laterally shifted by ~27 Å from the center of the TMD-density towards its edge (Figure 4A). Compared
to the membrane region of 4F2hc-LAT2, the ED of 4F2hc was well-defined. Thus, the X-ray structure of
4F2hc-ED (PDB ID code 2DH2, [6]) could nicely be fitted into the ED-density of the cryo-EM 3D-map
applying the volume-fit-procedure implemented in the Chimera software [25]. The best fit of the
4F2hc-ED structure with the ED-density was obtained if, (i), the N-terminal region (Figure 4, red colored
ribbon) faces the TMD-density, (ii), the TIM-barrel subdomain (Figure 4, cyan colored ribbon) is located
peripherally and, consequently, (iii), the eight antiparallel β-sheet containing C-terminal subdomain
(Figure 4, blue colored ribbon) aligns with the center of the TMD-density. This architecture tilts the
4F2hc-ED structure by approximately 20◦ with respect to the membrane plane. 4F2hc is composed
of a small cytoplasmic domain, one TMD, and a large ED. The N-terminal region of the 4F2hc-ED
structure thus represents the location of the disulfide bridge between 4F2hc and LAT2. In the 3D-map,
this region is laterally shifted with respect to the center of the TMD-density (Figure 4A,B, red colored
ribbon). Consequently, this model corroborates the observation based on the homology model of
human LAT2 (LAT2HM), that the Cys-residue involved in intersubunit disulfide bridge formation
(Cys-154) is located in a peripheral loop between the predicted TMDs 3 and 4 of LAT2HM [7].
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The larger density of the cryo-EM 3D-map, the TMD-density, reflects LAT2, the small 
cytoplasmic domain, the one TMD of 4F2hc, and co-purified lipids embedded in a LMNG/CHS 
detergent micelle. The TMD-density is approximately 145 Å in length, 115 Å in width, and 60 Å in 
height, and differs in appearance to the published negatively-stained TMD-density [7], which is 
approximately 100 Å in length, 60 Å in width, and 60 Å in height. The difference in length and width 
but not in height between the TMD-densities is attributed to the use of different purification 
detergents for structure determination resulting in differently sized micelles [26]. Moreover, the here 
described 3D-map originates from cryo-EM rather than negative-stain EM [7,13], where negative 
staining with heavy metal salt and drying of the sample are applied causing micellar size reduction 
[27]. 
In order to better understand the molecular architecture of 4F2hc-LAT2, we modeled the 
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Figure 4. Cryo-EM 3D-map at a resolution of ~13 Å. The 3D-map is displayed as viewed from the
extracellular side (A) and from the membrane plane (B,C). The 3D-map is composed of two densities.
The smaller and the larger densities are named ED- and TMD-density, respectively. The structure of
the 4F2hc-ED (PDB ID code 2DH2, [6]) was fitted into the ED-density and is shown as ribbon model.
The 4F2hc-ED structure is composed of an N-terminal region (red), a TIM-barrel subdomain (cyan),
and a C-terminal eight antiparallel β-strand subdomain (blue). The N-terminus (red) also reflects the
approximate location of the disulfide bridge between 4F2hc and LAT2. All 3D-maps are equally scaled
and the scale bar in panel C represents 100 Å.
The larger density of the cryo-EM 3D-map, the TMD-density, reflects LAT2, the small cytoplasmic
domain, the one TMD of 4F2hc, and co-purified lipids embedded in a LMNG/CHS detergent micelle.
The TMD-density is approximately 145 Å in length, 115 Å in width, and 60 Å in height, and differs
in appearance to the published negatively-stained TMD-density [7], which is approximately 100 Å
in length, 60 Å in width, and 60 Å in height. The difference in length and width but not in height
between the TMD-densities is attributed to the use of different purification detergents for structure
determination resulting in differently sized micelles [26]. Moreover, the here described 3D-map
originates from cryo-EM rather than negative-stain EM [7,13], where negative staining with heavy
metal salt and drying of the sample are applied causing micellar size reduction [27].
In order to better understand the molecular architecture of 4F2hc-LAT2, we modeled the
heterodimeric structure based on our cryo-EM 3D-map, the fitted 4F2hc-ED structure (PDB ID code
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2DH2, [6]), and LAT2HM, which is based on the structure of a bacterial L-arginine/agmatine antiporter
(amino acid sequence identity to LAT2: ~20%) [7]. The modeled 4F2hc-LAT2 structure revealed an
elongated arrangement of TMDs, which is best viewed from the cytoplasmic side (Figure 5).
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were used and 5 µg of purified 4F2hc-LAT2 loaded per lane. Electrophoresis was carried out as 
described by the protocol of the gel manufacturer. For Western blot analysis, the protein was 
transferred to a polyvinylidene difluoride (PVDF) membrane (Immobilon-P, Sigma). The membrane 
was blocked with 50 mM Tris-HCl pH 8.0, 150 mM NaCl, and 0.05% (v/v) Tween-20 containing 3% 
(w/v) bovine serum albumin (BSA) (Sigma). For anti-His detection the Penta-HisTM Antibody (Qiagen, 
Figure 5. Structural model of the 4F2hc-LAT2 heterodimeric complex based on the cryo-EM 3D-map.
The model is shown from the extracellular side (A), the membrane plane (B), and the cytoplasmic side
(C). The structure of 4F2hc-LAT2 is displayed as ribbon representation, and the structural elements
of 4F2hc-ED (PDB ID code 2DH2) are colored as in Figure 4 (N-terminal region, red; TIM-barrel
subdomain, cyan; C-terminal eight antiparallel β-strand subdomain, blue). Whereas the modeled TMD
of 4F2hc is shown in magenta, the LAT2 homology model (LAT2HM) is presented in orange. Individual
atoms of the disulfide bridge between 4F2hc and LAT2 are shown as green spheres. In panel (B) the
putative substrate entry side is represented by an L-Leu molecule (grey sticks) and an arrow.
3. M terials and Methods
.1. Cloning, Overexpression, and Purification of Human 4F2hc-LAT2
The generation of the Pichia pastoris human 4F2hc-LAT2 overexpression strain was reported
previously [12]. For protein production, a preculture of this strain in yeast-extract-peptone-dextrose
(YPD)-media contai ing Zeocin (1 µg/mL, Sig , St. Louis, MO, USA) was used to inocul te buffer
complex glycerol medium (BMGY), a d the c lt was grown at 30◦. At OD600 ~50, th medium
was changed t the buffered complex methanol expression medium (BMMY) containing 1% (v/v)
of ethanol. The cult re was allowe o grow for another 28 h at 30 ◦C before harvesting using
entrifugation at 10,000× g, 4 ◦C for 10 mi . The cell were r suspended in 50 mM Na-phosphate pH
7.4, 10% (v/v) glycerol, 1 mM EDTA (ethylenediaminetetraacetic acid), and lysed using 5 microfluidizer
(Mic ofluid cs) cycles at 1500 bar. Cell debris w re removed using centrifugation at 10,000× g, 4 ◦C for
10 min, and membranes were collected using ultracentrifugation t 150,000× g, 4◦C for 1 h. The crude
embranes were homogenized in 80 mM Bis-Tris propane pH 6.8, 300 mM NaCl, 10% (v/v) glycerol,
collected again using another ultracentrifugation round, homogenized, d l ted with 80 mM Bis-Tris
propane pH 6.8, 300 mM NaCl, 10% (v/v) lycerol to a concentration of 300 mg membranes per mL
and finally flash frozen and stored at −75 ◦C until further use.
The 4F2hc-LAT2 heteromeric complex was purified as reported previ usly usi g N -NTA affinity
chromatography [7,12,13]. The heteromeric complex was eluted from the Ni-NTA resin with 20 mM
Bis-Tris propane pH 6.8, 150 mM NaCl, 2% (v/v) glycerol, 0.01% (w/v) LMNG/CHS (5/1; w/w), 10 mM
oxid zed gluthathione, and 200 mM L- istidin , yielding 40 µg of pure 4F2hc-LAT2 hete odimeric
co plex per g of wet P. pastoris cells.
3.2. BN-PAGE and Western Blot Analysis
For BN-PAGE and Western blot analysis, 4–16% gradient gels (Invitrogen, Carlsbad, CA, USA)
were used and 5 µg of purified 4F2hc-LAT2 loaded per lane. Electrophoresis was carried out as
described by the protocol of the gel manufacturer. For Western blot analysis, the protein was
transferre to a polyvinylidene ifluoride (PVDF) membrane (Immobilon-P, Sigma). The membrane
was blocked with 50 mM Tris-HCl pH 8.0, 150 mM NaCl, and 0.05% (v/v) Tween-20 containi g 3%
(w/v) bovine serum albumin (BSA) (Sigma). For anti-His detection the Penta-HisTM Antibody (Qiagen,
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Hilden, Germany) was used as primary antibody and goat-anti-mouse IgG (H+L)-HPR conjugate
(Bio-Rad, Hercules, CA, USA) as secondary antibody. For anti-Strep detection the StrepMAB-Classic
HPR-conjugate (iba, Göttingen, Germany) was used. For the visualization of antibody labeled bands,
the PVDF membranes were treated with ECLTM solution according to the protocol of the manufacturer
(GE Healthcare, Chicago, IL, USA).
3.3. Grid Preparation and Cryo-EM Data Collection
Subsequently, after purification, the protein was diluted to 300 µg/mL with 20 mM Bis-Tris
propane pH 6.8, 150 mM NaCl, 2% (v/v) glycerol, 0.01% (w/v) LMNG/CHS (5/1; w/w), 10 mM
oxidized gluthathione, 200 mM L-histidine, and cryo-EM grids (R1.2/1.3 grids containing a 2 nm
carbon layer; Quantifoil) were prepared by adsorbing 2.5 µL of protein solution for 3 s on the carbon
layer of the glow discharged grids (12 s, 10 mA, 0.25 mbar) followed by three consecutive grid washing
steps with 200 µL ultrapure H2O for 10 s each. The grid was then plunge frozen in liquid ethane after
blotting off the excess water for 1 s using a Vitrobot Mark IV apparatus operated at approximately
100% humidity and cooled to 4–5 ◦C. The grids were stored in liquid nitrogen until further use.
Cryo-EM data was collected using a 200 kV FEI Tecnai F20 electron microscope equipped with a
Falcon III direct electron detector camera and VPP at a magnification of 100,000× and at a defocus
range of −0.6 to −1.2 µm. Data was collected in an automated fashion using the EPU software (FEI).
Images were recorded for 3 s with a frame exposure time of 77 ms and a dose of 1.9 e−/A2/frame,
resulting in a total accumulated dose on the specimen level of approximately 74 e−/Å2 per exposure.
3.4. Calculation of the Cryo-EM 3D-Map
Dose-fractioned images were motion-corrected and frames dose-weighted using MotionCor2 [28].
The contrast transfer function (CTF) parameters were estimated using ctffind 4.1.10 [29]. Images
of bad quality, e.g., strong drift, resolution above 6 Å, or phase shifts below 45◦ and above 135◦
according to CTF [21], and ice-contaminated images were selected and discarded using FOCUS
software [30]. The remaining 691 images were used for image processing with RELION 3 [22]. An
initial set of 3,297 particles from a small set of images were picked by the Laplacian-of-Gaussian
filter using the auto-picking procedure of RELION 3. 2D-class averages were calculated, and those
selected were used to auto-pick 235,830 particles. Particles belonging to low-abundance classes were
removed by 4 rounds of 2D-classification. The remaining particles were used to generate an initial
model calculated using the stochastic-gradient-descent algorithm of RELION 3 and used for a first
round of 3D-classification. An iterative procedure was employed for subsequent 3D-classification and
refinement rounds using the best output 3D-maps. Finally, a single 3D-class, including 47,933 particles,
was subjected to auto-refinement in RELION. The FSC of the final unmasked 3D-map was calculated
by applying the postprocess procedure implemented in the RELION software. Based on the FSC curve,
the resolution was determined at the 0.5 and 0.143 (gold standard) FSC-cut-off-criteria to 14.3 Å and
12.9 Å, respectively.
3.5. Modeling the 4F2hc-LAT2 Structure
The rotational and translational position of the LAT2 homology model (LAT2HM) [7] in
a membrane was calculated using the positioning of proteins in membrane (PPM) server [31].
The procedure for positioning of the LAT2HM into the cryo-EM TMD-density was done as follows:
First, the center of mass of the LAT2HM was placed in the center of the TMD-density. Second, based on
the PPM-server output, the respective vertical axes of the LAT2HM and the TMD-density were aligned.
Third, the LAT2HM was rotated along the vertical axes such that the Cys residues of 4F2hc and LAT2
involved in disulfide bridge formation horizontally align. In order to visualize the TMD of 4F2hc,
the fitted 4F2hc-ED structure was N-terminally extended by modeling a straight, with respect to the
membrane plane orthogonal 29 Ala residues containing and ~42 Å long α-helix using COOT [32].
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3.6. Figure Preparation
Molecular graphics and analyses were performed with UCSF Chimera [25].
4. Conclusions
In this study we purified the in Pichia pastoris heterologously overexpressed human 4F2hc-LAT2
heterodimeric complex. The protein complex was obtained pure and correctly assembled based on
BN-PAGE and cryo-EM. Furthermore, we have determined the first 3D cryo-EM structure of the
human 4F2hc-LAT2 heterodimeric complex at ~13 Å resolution. The usage of the VPP for cryo-EM data
collection was deemed crucial due to otherwise too low image contrast. The structure revealed two
major densities of which the smaller one was identified as the 4F2hc-ED. The larger, micellar density is
therefore composed of LAT2 plus the cytoplasmic domain and the TMD of 4F2hc and co-purified lipids
embedded in a LMNG/CHS micelle. The X-ray structure of 4F2hc-ED nicely fitted into the smaller
density (Figure 4; ED-density and Figure 5). This experimentally revealed that 4F2hc-ED is laterally
shifted by ~27 Å from the center of the micellar density and tilted by ~20◦ with respect to LAT2 and
the membrane plane. The larger density, the TMD-density, resembled an oblate ellipsoid. In order
to investigate the TMD-density further, we generated an in silico model of the 4F2hc-LAT2 structure
based on our cryo-EM 3D-map. In this model, the LAT2HM is located in the center of the TMD-density
and positioned such that the Cys residues of 4F2hc-ED and the LAT2HM responsible for intersubunit
disulfide bridge formation are in close proximity (Figure 5, green spheres). In addition, the one TMD
of 4F2hc was modeled (Figure 5, magenta colored α-helix). With this, an elongated arrangement of
all 13 TMDs of 4F2hc-LAT2 is discerned (Figure 5C). As a consequence, this TMD arrangement may
explain why the TMD-density resembles an oblate ellipsoid. In addition, the presented architecture of
the 4F2hc-LAT2 structure provides a substrate entry point and would therefore allow for relatively
unhindered substrate binding to the catalytic HAT subunit LAT2 (Figure 5B). In summary, the here
presented cryo-EM 3D-map of human 4F2hc-LAT2 provided new insights on the molecular architecture
of this complex revealing the relative position of 4F2hc with respect to LAT2 and the membrane plane
under near native conditions. Moreover, this work paves the way for high-resolution structure solution
using cryo-EM of human 4F2hc-LAT2 and HATs in general.
Supplementary Materials: Supplementary Table 1 (Table S1) can be found at http://www.mdpi.com/1422-0067/
20/4/931/s1.
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